An update on breast cancer screening.

Screening mammograms have received too much bad press recently!  


In the NY Times Oct 24, by Tara Parker-Pope and in the Washington Post Oct 31, by Manoj Jain, each author chose to compare PSA screening for prostate cancer to mammographic screening for breast cancer, despite the fact that the benefits, risks and science behind each is quite different.  There is not nearly the evidence for the value of PSA screening as there is evidence for LIVES SAVED by screening mammography. 


I will rehash all of the studies showing that screening mammograms SAVE LIVES in a future blog, but more immediately offer an option for those women dissuaded from mammography by the recent "news" articles.


A new test would seem to be an excellent option to find out who would benefit the most from screening mammography by giving us information on personal risk.  Those at higher risk could benefit the most from the screening and intervention.  


One such test is the BREVAGen test, which has been validated by science (see my blog 09-12-2011).  We have used it to learn who is at higher risk for breast cancer and then offer appropriate screening and intervention.  The test is without radiation or false positive risk.  It is an inner cheek swab plus personal clinical data.  The results are easy to understand, quite convincing and can be compared to the meaning of the cholesterol level to heart attack risk.


Join my blog or call to come in to learn more or have the test done.